Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Quasi-Classical Trajectory Study of NH(3-) + NH(3-) Reactive Collisions.

de Castro DG, Poveda LA, Crispim LWS, Ballester MY.

J Phys Chem A. 2019 Oct 10. doi: 10.1021/acs.jpca.9b08278. [Epub ahead of print]

PMID:
31573199
2.

NUQA: Estimating cancer spatial and temporal heterogeneity and evolution through alignment-free methods.

Roddy AC, Jurek A, Souza J, Gilmore A, O'Reilly PG, Stupnikov A, de Castro DG, Prise KM, Salto-Tellez M, McArt DG.

Mol Biol Evol. 2019 Aug 19. pii: msz182. doi: 10.1093/molbev/msz182. [Epub ahead of print]

PMID:
31424551
3.

Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis.

Coelho TM, Fogaroli RC, Pellizzon ACA, De Castro DG, Gondim GRM, Silva MLG, Chen MJ, Ramos H.

Radiat Oncol. 2018 Nov 20;13(1):224. doi: 10.1186/s13014-018-1168-x.

4.

Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma.

Ghosh S, Baker S, de Castro DG, Kepka L, Kumar N, Sinaika V, Matiello J, Lomidze D, Dyttus-Cebulok K, Rosenblatt E, Fidarova E, Roa W.

Radiother Oncol. 2018 Apr;127(1):114-120. doi: 10.1016/j.radonc.2018.01.017. Epub 2018 Feb 13.

PMID:
29452901
5.

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer.

Sclafani F, Chau I, Cunningham D, Hahne JC, Vlachogiannis G, Eltahir Z, Lampis A, Braconi C, Kalaitzaki E, De Castro DG, Wotherspoon A, Capdevila J, Glimelius B, Tarazona N, Begum R, Lote H, Hulkki Wilson S, Mentrasti G, Brown G, Tait D, Oates J, Valeri N.

Sci Rep. 2018 Jan 23;8(1):1445. doi: 10.1038/s41598-018-19212-5.

6.

Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours.

Izquierdo E, Yuan L, George S, Hubank M, Jones C, Proszek P, Shipley J, Gatz SA, Stinson C, Moore AS, Clifford SC, Hicks D, Lindsey JC, Hill RM, Jacques TS, Chalker J, Thway K, O'Connor S, Marshall L, Moreno L, Pearson A, Chesler L, Walker BA, De Castro DG.

Oncotarget. 2017 Dec 6;8(67):112036-112050. doi: 10.18632/oncotarget.23000. eCollection 2017 Dec 19.

7.

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.

Capoluongo E, Ellison G, López-Guerrero JA, Penault-Llorca F, Ligtenberg MJL, Banerjee S, Singer C, Friedman E, Markiefka B, Schirmacher P, Büttner R, van Asperen CJ, Ray-Coquard I, Endris V, Kamel-Reid S, Percival N, Bryce J, Röthlisberger B, Soong R, de Castro DG.

Semin Oncol. 2017 Jun;44(3):187-197. doi: 10.1053/j.seminoncol.2017.08.004. Epub 2017 Sep 15. Review.

8.

An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice.

Ellison G, Ahdesmäki M, Luke S, Waring PM, Wallace A, Wright R, Röthlisberger B, Ludin K, Merkelbach-Bruse S, Heydt C, Ligtenberg MJL, Mensenkamp AR, de Castro DG, Jones T, Vivancos A, Kondrashova O, Pauwels P, Weyn C, Hahnen E, Hauke J, Soong R, Lai Z, Dougherty B, Carr TH, Johnson J, Mills J, Barrett JC.

Hum Mutat. 2018 Mar;39(3):394-405. doi: 10.1002/humu.23375. Epub 2017 Dec 28.

9.

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma.

Lee JY, Garcia-Murillas I, Cutts RJ, De Castro DG, Grove L, Hurley T, Wang F, Nutting C, Newbold K, Harrington K, Turner N, Bhide S.

Br J Cancer. 2017 Sep 5;117(6):876-883. doi: 10.1038/bjc.2017.258. Epub 2017 Aug 15.

10.

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.

Hiley CT, Le Quesne J, Santis G, Sharpe R, de Castro DG, Middleton G, Swanton C.

Lancet. 2016 Sep 3;388(10048):1002-11. doi: 10.1016/S0140-6736(16)31340-X. Epub 2016 Sep 1. Review.

PMID:
27598680
11.

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients.

Sclafani F, Chau I, Cunningham D, Lampis A, Hahne JC, Ghidini M, Lote H, Zito D, Tabernero J, Glimelius B, Cervantes A, Begum R, De Castro DG, Wilson SH, Peckitt C, Eltahir Z, Wotherspoon A, Tait D, Brown G, Oates J, Braconi C, Valeri N.

Carcinogenesis. 2016 Sep;37(9):852-7. doi: 10.1093/carcin/bgw073. Epub 2016 Jul 5.

12.

Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients.

Socha J, Kepka L, Ghosh S, Roa W, Kumar N, Sinaika V, Matiello J, Lomidze D, de Castro DG, Hentati D, Fidarova E.

J Neurooncol. 2016 Feb;126(3):493-8. doi: 10.1007/s11060-015-1987-7. Epub 2015 Nov 5.

PMID:
26542030
13.

Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.

de Azevedo Santos TR, Tundisi CF, Ramos H, Maia MA, Pellizzon AC, Silva ML, Fogaroli RC, Chen MJ, Suzuki SH, Dias JE Jr, Sanematsu PI Jr, de Castro DG.

Radiat Oncol. 2015 Mar 8;10:63. doi: 10.1186/s13014-015-0367-y.

14.

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.

Parry M, Rose-Zerilli MJ, Ljungström V, Gibson J, Wang J, Walewska R, Parker H, Parker A, Davis Z, Gardiner A, McIver-Brown N, Kalpadakis C, Xochelli A, Anagnostopoulos A, Fazi C, de Castro DG, Dearden C, Pratt G, Rosenquist R, Ashton-Key M, Forconi F, Collins A, Ghia P, Matutes E, Pangalis G, Stamatopoulos K, Oscier D, Strefford JC.

Clin Cancer Res. 2015 Sep 15;21(18):4174-4183. doi: 10.1158/1078-0432.CCR-14-2759. Epub 2015 Mar 16.

15.

Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.

Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, de Castro DG, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA.

J Clin Pathol. 2015 Feb;68(2):111-8. doi: 10.1136/jclinpath-2014-202644. Epub 2014 Nov 27.

16.

Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial.

Lopes AC, Greenberg BD, Canteras MM, Batistuzzo MC, Hoexter MQ, Gentil AF, Pereira CA, Joaquim MA, de Mathis ME, D'Alcante CC, Taub A, de Castro DG, Tokeshi L, Sampaio LA, Leite CC, Shavitt RG, Diniz JB, Busatto G, Norén G, Rasmussen SA, Miguel EC.

JAMA Psychiatry. 2014 Sep;71(9):1066-76. doi: 10.1001/jamapsychiatry.2014.1193.

PMID:
25054836
17.

A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.

Le Quesne J, Maurya M, Yancheva SG, O'Brien M, Popat S, Wotherspoon AC, de Castro DG, Nicholson AG.

J Thorac Oncol. 2014 Jun;9(6):769-74. doi: 10.1097/JTO.0000000000000157.

18.

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.

Deans ZC, Bilbe N, O'Sullivan B, Lazarou LP, de Castro DG, Parry S, Dodson A, Taniere P, Clark C, Butler R.

J Clin Pathol. 2013 Apr;66(4):319-25. doi: 10.1136/jclinpath-2012-201227. Epub 2013 Feb 1.

PMID:
23378269
19.

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib.

Lopez-Rios F, Angulo B, Gomez B, Mair D, Martinez R, Conde E, Shieh F, Vaks J, Langland R, Lawrence HJ, de Castro DG.

PLoS One. 2013;8(1):e53733. doi: 10.1371/journal.pone.0053733. Epub 2013 Jan 10.

20.

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.

Stemke-Hale K, Shipman K, Kitsou-Mylona I, de Castro DG, Hird V, Brown R, Flanagan J, Gabra H, Mills GB, Agarwal R, El-Bahrawy M.

Mod Pathol. 2013 Apr;26(4):544-52. doi: 10.1038/modpathol.2012.194. Epub 2012 Nov 23.

21.

Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma.

Marconi DG, de Castro DG, Rebouças LM, Bernardes Gil GO, Fogaroli RC, Conte Maia MA, Gobo Silva ML, Assis Pellizzon AC, Motono Chojniak MM.

Brachytherapy. 2013 May-Jun;12(3):235-9. doi: 10.1016/j.brachy.2012.01.012. Epub 2012 Mar 20.

PMID:
22436517
22.

Challenges for the implementation of routine molecular diagnostics in cancer care.

de Castro DG.

Expert Rev Mol Diagn. 2011 Jul;11(6):549-51. doi: 10.1586/erm.11.37. No abstract available.

PMID:
21745007
23.

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Foroni L, Wilson G, Gerrard G, Mason J, Grimwade D, White HE, de Castro DG, Austin S, Awan A, Burt E, Clench T, Farruggia J, Hancock J, Irvine AE, Kizilors A, Langabeer S, Milner BJ, Nickless G, Schuh A, Sproul A, Wang L, Wickham C, Cross NC.

Br J Haematol. 2011 Apr;153(2):179-90. doi: 10.1111/j.1365-2141.2011.08603.x. Epub 2011 Mar 8.

PMID:
21382019
24.

Immunologically silent cancer clone transmission from mother to offspring.

Isoda T, Ford AM, Tomizawa D, van Delft FW, De Castro DG, Mitsuiki N, Score J, Taki T, Morio T, Takagi M, Saji H, Greaves M, Mizutani S.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17882-5. doi: 10.1073/pnas.0904658106. Epub 2009 Oct 12.

25.

A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin.

Russell LJ, De Castro DG, Griffiths M, Telford N, Bernard O, Panzer-Grümayer R, Heidenreich O, Moorman AV, Harrison CJ.

Leukemia. 2009 Mar;23(3):614-7. doi: 10.1038/leu.2008.250. Epub 2008 Sep 25. No abstract available.

PMID:
18818706
26.

[Radiosurgery for pituitary adenomas].

de Castro DG, Salvajoli JV, Canteras MM, Cecílio SA.

Arq Bras Endocrinol Metabol. 2006 Dec;50(6):996-1004. Review. Portuguese.

PMID:
17221104

Supplemental Content

Loading ...
Support Center